Cochrane COVID-19 Studienregister
Studienbericht
NCT05074888Erstmals veröffentlicht: 2021 Okt 12Letzte Aktualisierung: 2021 Okt 12

A Multicenter, Double-blind, Placebo-controlled, Parallel-group, Randomized Clinical Trial of Efficacy and Safety of Prospekta in the Treatment of Patients With Post-COVID-19 Asthenia

  1. Studientyp
  2. Interventional
  1. Studienziel
  2. Treatment and Management
  1. Studiendesign
  2. Parallel/Crossover
  1. Interventionszuordnung
  2. Randomised
Referenzdatensätze

Сlinical Trial of Efficacy and Safety of Prospekta in the Treatment of Post-COVID-19 Asthenia

Materia Medica Holding
Erstmals veröffentlicht (first received 2021 October 12)ClinicalTrials.gov (https://clinicaltrials.gov/show/NCT05074888)
Eintrag in Studienregister
Keine Ergebnisse
The multicenter, double-blind, placebo-controlled, parallel-group, randomized clinical trial. The objective of this study is to evaluate the efficacy and safety of Prospekta in the treatment of asthenia in patients after the coronavirus infectious disease (COVID-19)